Brief: Oncocyte Reports Second Quarter 2022 Financial Results
Aug 10 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.07
* Q2 REVENUE $2.1 MILLION
* TOTAL REVENUE WAS $2.1 MILLION FOR Q2 OF 2022, COMPARED TO
$1.4
MILLION FOR PRIOR QUARTER
* QTRLY NET LOSS PER SHARE WAS $0.07
* Q2 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $2.7
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9DlmTj
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission